Identification of the metabolites produced following Iris tectorum Maxim oral administration and a network pharmacology-based analysis of their potential pharmacological properties

References

• Bai, X., et al., 2010. Isolation and identification of urinary metabolites of kakkalide in rats. Drug metabolism and disposition: the biological fate of chemicals, 38 (2), 281–286.
   PubMed Web of Science ®Google Scholar
• Bai, X., et al., 2014. Excretion of tectorigenin in rat urine orally administrated at different dosages by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. European journal of drug metabolism and pharmacokinetics, 40 (3), 255–266.
   PubMed Web of Science ®Google Scholar
• Buemi, M.R., et al., 2019. Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety. European journal of medicinal chemistry, 163, 443–452.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2008. Identification of metabolites of tectoridin in-vivo and in-vitro by liquid chromatography-tandem mass spectrometry. The journal of pharmacy and pharmacology, 60 (6), 709–716.
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA. 2017. Discovery Studio Modeling Environment. San Diego CA: Dassault Systèmes.
   Google Scholar
• Fang, R., et al., 2007. Isolation and structure determination of triterpenes from Iris tectorum. Phytochemistry, 68 (9), 1242–1247.
   PubMed Web of Science ®Google Scholar
• Fang, R., Houghton, P.J., and Hylands, P.J., 2008. Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines. Journal of ethnopharmacology, 118 (2), 257–263.
   PubMed Web of Science ®Google Scholar
• Gao, B., et al., 2021. Identification and characterization of the chemical components of Iris tectorum Maxim. and evaluation of their nitric oxide inhibitory activity. Rapid communications in mass spectrometry, 35 (1), e8959.
   PubMed Web of Science ®Google Scholar
• Han, T., et al., 2012. In vitro evaluation of tectoridin, tectorigenin and tectorigenin sodium sulfonate on antioxidant properties. Food and chemical toxicology, 50 (2), 409–414.
   PubMed Web of Science ®Google Scholar
• Kang, K.S., et al., 2009. Tectoridin, a poor ligand of estrogen receptor alpha, exerts its estrogenic effects via an ERK-dependent pathway. Molecules and cells, 27 (3), 351–357.
   PubMed Web of Science ®Google Scholar
• Lee, H.U., Bae, E.A., and Kim, D.H., 2005. Hepatoprotective Effect of tectoridin and tectorigenin on tert-butyl hyperoxide-induced liver injury. Journal of pharmacological sciences, 97 (4), 541–544.
   PubMed Web of Science ®Google Scholar
• Li, S., and Zhang, B., 2013. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese journal of natural medicines, 11 (2), 110–120.
   PubMed Web of Science ®Google Scholar
• Ma, Y.H., et al., 2012. C-glycosylflavones from the leaves of Iris tectorum Maxim. Acta Pharmaceutica Sinica B, 2 (6), 598–601.
   Google Scholar
• Pan, C.H., et al., 2008. Tectorigenin Inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells. Archives of pharmacal research, 31 (11), 1447–1456.
   PubMed Web of Science ®Google Scholar
• Qu, J.L., et al., 2012. Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 902, 61–69.
   PubMed Web of Science ®Google Scholar
• Qu, J.L., et al., 2014. Excretion of tectoridin metabolites in rat urine and bile orally administrated at different dosages and their inhibitory activity against aldose reductase. Fitoterapia, 99, 99–108.
   PubMed Web of Science ®Google Scholar
• Sarda, S., et al., 2014. HPLC–MS profiling and structural identification of [14C]‑diclofenac metabolites in mouse bile. Chromatographia, 77 (3–4), 233–239.
   Web of Science ®Google Scholar
• Shin, J.E., et al., 2006. Estrogenic effect of main components kakkalide and tectoridin of Puerariae flos and their metabolites. Biological & pharmaceutical bulletin, 29 (6), 1202–1206.
   PubMed Web of Science ®Google Scholar
• Shu, P., et al., 2010. Analysis of flavonoids and phenolic acids in Iris tectorum by HPLC-DAD-ESI-MSn. Chinese journal of natural medicines, 8 (3), 202–207.
   Google Scholar
• Takahashi, K., et al., 2000. Iridals from Iris tectorum and Belamcanda chinensis. Phytochemistry, 53 (8), 925–929.
   PubMed Web of Science ®Google Scholar
• The State Commission of Chinese Pharmacopoeia. 2015. Part I. Pharmacopoeia of People’s Republic of China. Beijing: China Medical Science Press, 41–42.
   Google Scholar
• Vernier, W., et al., 2010. Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation. Bioorganic & medicinal chemistry, 18 (9), 3307–3319.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., et al., 2010. Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice. Toxicology, 276 (1), 64–72.
   PubMed Web of Science ®Google Scholar
• Xie, G.Y., et al., 2014. Phenolic metabolite profiles and antioxidants assay of three Iridaceae medicinal plants for traditional Chinese medicine "She-gan" by on-line HPLC-DAD coupled with chemiluminescence (CL) and ESI-Q-TOF-MS/MS. Journal of pharmaceutical and biomedical analysis, 98, 40–51.
   PubMed Web of Science ®Google Scholar
• Yang, M., et al., 2015. Comparative pharmacokinetic profiles of tectorigenin in rat plasma by UPLC-MS/MS after oral administration of Iris tectorum Maxim extract and pure tectoridin. Journal of pharmaceutical and biomedical analysis, 114, 34–41.
   PubMed Web of Science ®Google Scholar
• Zakšauskas, A., et al., 2018. Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases. European journal of medicinal chemistry, 156, 61–78.
   PubMed Web of Science ®Google Scholar
• Zhang, W.D., et al., 2011. Simultaneous determination of tectorigenin, irigenin and irisflorentin in rat plasma and urine by UHPLC-MS/MS: application to pharmacokinetics. Journal of chromatography B, 879 (31), 3735–3741.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2014. Iridal-type triterpenoids with neuroprotective activities from Iris tectorum. Journal of natural products, 77 (2), 411–415.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2015a. Polycycloiridals A-D, four iridal-type triterpenoids with an α-terpineol moiety from Iris tectorum. Organic letters, 17 (22), 5686–5689.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2015b. Cytotoxic iridal-type triterpenoids from Iris tectorum. Tetrahedron, 71 (34), 5579–5583.
   Web of Science ®Google Scholar
• Zhang, C.L., et al., 2016a. Two new flavonoid glycosides from Iris tectorum. Phytochemistry letters, 15, 63–65.
   Web of Science ®Google Scholar
• Zhang, C.L., et al., 2016b. Lignans from the rhizomes of Iris tectorum. Fitoterapia, 108, 93–97.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2017a. Iritectol G, a novel iridal-type triterpenoid from Iris tectorum displays anti-epileptic activity in vitro through inhibition of sodium channels. Fitoterapia, 122, 20–25.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2017b. Polycycloiridals with a cyclopentane ring from Iris tectorum. Journal of natural products, 80 (1), 156–161.
   PubMed Web of Science ®Google Scholar
• Zhang, C.L., et al., 2017c. Apocynin derivatives from Iris tectorum. Journal of Asian natural products research, 19 (2), 128–133.
   PubMed Web of Science ®Google Scholar